Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Meer aandacht nodig voor functionele bewegingsstoornissen
feb 2021 | Bewegingsstoornissen